Valuation: Integer Holdings Corp

Market Cap 4.26B 3.68B 3.44B 3.16B 5.93B 405B 6.03B 40.36B 15.84B 203B 15.99B 15.64B 672B P/E 2026 *
40.2x
P/E 2027 * 27x
Enterprise Value 4.26B 3.68B 3.44B 3.16B 5.93B 405B 6.03B 40.36B 15.84B 203B 15.99B 15.64B 672B EV / Sales 2026 *
2.34x
EV / Sales 2027 * 2.21x
Free-Float
94.45%
Yield 2026 *
-
Yield 2027 * -
Manager TitleAgeSince
Chief Executive Officer 56 2025-10-23
Director of Finance/CFO 53 2023-05-07
Chief Tech/Sci/R&D Officer - 2018-12-31
Director TitleAgeSince
Director/Board Member 67 2015-07-01
Director/Board Member 68 2015-07-01
Chairman 72 2026-05-19
Change 5-day change 1-year change 3-year change Capi.($)
+2.41%+3.43%+28.93%+6.88% 220B
+2.39%+5.02%+2.09%-20.96% 144B
+1.36%+7.21%-19.42%+25.07% 134B
+0.02%+5.52%-52.19%-2.51% 71.46B
+0.45%+4.24%+14.51%+14.16% 51.71B
+1.05%+7.19%-14.90%-17.93% 50.84B
+3.28%+5.49%+27.35%+13.73% 41.23B
+1.79%+7.83%+44.69%+37.11% 39.95B
+2.08%+5.51%-0.32%-2.92% 32.42B
Average +1.65%+5.55%+3.42%+5.85% 87.22B
Weighted average by Cap. +1.79%+5.17%+4.10%+4.39%

Financials

2026 *2027 *
Net sales 1.82B 1.57B 1.47B 1.35B 2.54B 173B 2.58B 17.26B 6.77B 86.85B 6.84B 6.69B 287B 1.93B 1.67B 1.56B 1.43B 2.69B 184B 2.73B 18.28B 7.18B 92.03B 7.24B 7.09B 304B
Net income 112M 97.25M 90.82M 83.31M 157M 10.7B 159M 1.07B 418M 5.36B 422M 413M 17.73B 158M 137M 128M 117M 220M 15.04B 224M 1.5B 588M 7.54B 594M 581M 24.93B
Net Debt - -
Logo Integer Holdings Corp
Integer Holdings Corporation is a medical device contract development and manufacturing company. The Company serves the cardiac rhythm management, neuromodulation, and cardio and vascular markets. Its brands include Greatbatch Medical and Lake Region Medical. The Company’s Cardio & Vascular product line offers a range of components, subassemblies, and finished devices used in interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, urology, and gastroenterology procedures. Its interventional cardiology portfolio is focused primarily on the design, development and manufacture of catheter and wire-based technologies intended to diagnose and treat cardiac disease. Its electrophysiology products include devices used by electrophysiologists and interventional cardiologists for the treatment of cardiac arrythmias, such as atrial fibrillation.
Employees
-
Trader
Investor
Global
Quality
ESG MSCI
-